19-44913034-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000623895.1(ENSG00000280087):​n.3660C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.349 in 152,028 control chromosomes in the GnomAD database, including 9,788 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.35 ( 9784 hom., cov: 32)
Exomes 𝑓: 0.44 ( 4 hom. )

Consequence

ENSG00000280087
ENST00000623895.1 non_coding_transcript_exon

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -3.00

Publications

29 publications found
Variant links:
Genes affected
APOC1 (HGNC:607): (apolipoprotein C1) This gene encodes a member of the apolipoprotein C1 family. This gene is expressed primarily in the liver, and it is activated when monocytes differentiate into macrophages. The encoded protein plays a central role in high density lipoprotein (HDL) and very low density lipoprotein (VLDL) metabolism. This protein has also been shown to inhibit cholesteryl ester transfer protein in plasma. A pseudogene of this gene is located 4 kb downstream in the same orientation, on the same chromosome. This gene is mapped to chromosome 19, where it resides within a apolipoprotein gene cluster. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Sep 2016]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000623895.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.403 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000623895.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ENSG00000280087
ENST00000623895.1
TSL:6
n.3660C>T
non_coding_transcript_exon
Exon 1 of 1
APOC1
ENST00000876409.1
c.-482C>T
upstream_gene
N/AENSP00000546468.1

Frequencies

GnomAD3 genomes
AF:
0.349
AC:
53054
AN:
151856
Hom.:
9786
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.253
Gnomad AMI
AF:
0.502
Gnomad AMR
AF:
0.305
Gnomad ASJ
AF:
0.374
Gnomad EAS
AF:
0.211
Gnomad SAS
AF:
0.291
Gnomad FIN
AF:
0.489
Gnomad MID
AF:
0.332
Gnomad NFE
AF:
0.407
Gnomad OTH
AF:
0.373
GnomAD4 exome
AF:
0.444
AC:
24
AN:
54
Hom.:
4
Cov.:
0
AF XY:
0.500
AC XY:
21
AN XY:
42
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
2
American (AMR)
AF:
0.500
AC:
1
AN:
2
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AF:
0.500
AC:
1
AN:
2
European-Finnish (FIN)
AF:
0.667
AC:
4
AN:
6
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.447
AC:
17
AN:
38
Other (OTH)
AF:
0.250
AC:
1
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.553
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.349
AC:
53073
AN:
151974
Hom.:
9784
Cov.:
32
AF XY:
0.350
AC XY:
26002
AN XY:
74278
show subpopulations
African (AFR)
AF:
0.253
AC:
10480
AN:
41484
American (AMR)
AF:
0.305
AC:
4652
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.374
AC:
1298
AN:
3466
East Asian (EAS)
AF:
0.211
AC:
1087
AN:
5144
South Asian (SAS)
AF:
0.292
AC:
1409
AN:
4826
European-Finnish (FIN)
AF:
0.489
AC:
5162
AN:
10564
Middle Eastern (MID)
AF:
0.323
AC:
95
AN:
294
European-Non Finnish (NFE)
AF:
0.407
AC:
27648
AN:
67904
Other (OTH)
AF:
0.372
AC:
784
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1740
3480
5221
6961
8701
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
524
1048
1572
2096
2620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.322
Hom.:
3604
Bravo
AF:
0.333
Asia WGS
AF:
0.235
AC:
818
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.017
DANN
Benign
0.69
PhyloP100
-3.0

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs59325138;
hg19: chr19-45416291;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.